clinical trial · NCT06991348
Clinical Trial for the Comparative Evaluation of Acid Suppression and Symptom Management of Gastroesophageal Reflux Disease With the Administration of Tegoprazan or Pantoprazole
Carnot Laboratories·phase4·recruiting·n = 128
Gastroesophageal Reflux DiseaseTegoprazanPantoprazole
brief summary
The objective of this clinical trial is to compare which of the two drugs best resolves symptoms in patients diagnosed with erosive and non-erosive gastroesophageal reflux disease, adult males and females. The main question is What is the proportion of patients with resolution of the main symptoms of gastroesophageal reflux disease at four weeks of treatment with pantoprazole vs tegoprazan.
started
Jul 30, 2024
primary completion
Nov 30, 2025
completion
Nov 30, 2025
last updated
Jul 23, 2025
official title
Multicenter, Active-controlled, Randomized, Double-blind, Clinical Trial for the Comparative Evaluation of Acid Suppression and Symptom Management of Gastroesophageal Reflux Disease With the Administration of Tegoprazan or Pantoprazole: TOP-GERD
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol